Expert consensus on microwave ablation for benign breast nodules.
10.3760/cma.j.cn112138-20221123-00884
- Collective Name:Society of Tumor Ablation Therapy of the Chinese Anti-Cancer Association;Ablation Expert Committee of the Chinese Society of Clinical Oncology;Society of Tumor Ablation Therapy of Chinese College of Interventionalists;Expert Group on Tumor Ablation Therapy of the Chinese Medical Doctors Association
- Publication Type:Journal Article
- MeSH:
Humans;
Consensus;
Microwaves/therapeutic use*;
Catheter Ablation;
Thyroid Nodule/surgery*;
Radiofrequency Ablation;
Treatment Outcome
- From:
Chinese Journal of Internal Medicine
2023;62(4):369-373
- CountryChina
- Language:Chinese
-
Abstract:
Because mammary glands are regulated by endocrine factors, they are prone to various abnormalities and disorders. Breast nodules are common and occur frequently in clinical practice. The clinical management of breast nodules mainly includes follow-up observation, lesion biopsy, and surgical intervention, and surgical intervention is an effective treatment. Ultrasound-guided percutaneous microwave ablation is a new minimally invasive treatment technology developed in recent years. It has the advantages of short operation time, no scarring, less damage to the lactiferous duct, quick recovery, and good curative effects without bleeding. The establishment of an expert consensus on microwave ablation for benign breast nodules aims to provide a reliable clinical basis for microwave ablation of benign breast nodules, standardize the treatment process, and improve treatment efficacy, so as to serve as a reference for physicians in clinical practice.
